Completed
A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.
NCT04573556
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- Eisai trial site 1 Nagoya, Japan
- Eisai trial site 2 Osaka, Japan
- Eisai trial site 3 Tokyo, Japan